| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $130.5M | -8.1% |
| SG&A Expense | $46.7M | +46.5% |
| Operating Income | -$179.7M | -6.9% |
| Interest Expense | $45.1M | +406.1% |
| Pre-tax Income | -$208.4M | -20.3% |
| Income Tax | -$20K | +99.9% |
| Net Income | -$208.4M | -40.0% |
| EPS (Basic) | -$1.20 | +23.6% |
| EPS (Diluted) | -$1.20 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $239.6M | -37.4% |
| Accounts Receivable | $109K | -9.9% |
| Current Assets | $275.3M | -35.3% |
| Total Assets | $375.4M | -23.4% |
| Current Liabilities | $44.7M | -3.5% |
| Total Liabilities | $263.9M | +37.7% |
| Stockholders' Equity | $111.5M | -62.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.6M | -29.6% |
| Capital Expenditures | $11.0M | +1.3% |
| Investing Cash Flow | -$11.0M | -1.3% |
| Financing Cash Flow | -$883K | -100.4% |
| Free Cash Flow | -$156.6M | -27.1% |
| +23.6% |